132 related articles for article (PubMed ID: 38626801)
21. Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012.
Butler SS; Muralidhar V; Zhao SG; Sanford NN; Franco I; Fullerton ZH; Chavez J; D'Amico AV; Feng FY; Rebbeck TR; Nguyen PL; Mahal BA
Cancer; 2020 Feb; 126(4):717-724. PubMed ID: 31794057
[TBL] [Abstract][Full Text] [Related]
22. Impact of an NCCN-Compliant Multidisciplinary Conference on Treatment Decisions for Localized Prostate Cancer.
Hussein AA; Iqbal U; Jing Z; Ramahi Y; Houenstein H; Newman S; Peterson B; Krajacic K; Samoni A; Xu B; Sule N; Azabdaftari G; Kauffman EC; Mohler JL; Kuettel M; Guru KA
J Natl Compr Canc Netw; 2023 Apr; 21(4):359-365.e4. PubMed ID: 37015336
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.
Carroll PR; Parsons JK; Andriole G; Bahnson RR; Barocas DA; Catalona WJ; Dahl DM; Davis JW; Epstein JI; Etzioni RB; Giri VN; Hemstreet GP; Kawachi MH; Lange PH; Loughlin KR; Lowrance W; Maroni P; Mohler J; Morgan TM; Nadler RB; Poch M; Scales C; Shanefelt TM; Vickers AJ; Wake R; Shead DA; Ho M;
J Natl Compr Canc Netw; 2014 Sep; 12(9):1211-9; quiz 1219. PubMed ID: 25190691
[TBL] [Abstract][Full Text] [Related]
24. NCCN Guidelines® Insights: Palliative Care, Version 2.2021.
Dans M; Kutner JS; Agarwal R; Baker JN; Bauman JR; Beck AC; Campbell TC; Carey EC; Case AA; Dalal S; Doberman DJ; Epstein AS; Fecher L; Jones J; Kapo J; Lee RT; Loggers ET; McCammon S; Mitchell W; Ogunseitan AB; Portman DG; Ramchandran K; Sutton L; Temel J; Teply ML; Terauchi SY; Thomas J; Walling AM; Zachariah F; Bergman MA; Ogba N; Campbell M
J Natl Compr Canc Netw; 2021 Jul; 19(7):780-788. PubMed ID: 34340208
[TBL] [Abstract][Full Text] [Related]
25. Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations.
Van den Broeck T; van den Bergh RCN; Briers E; Cornford P; Cumberbatch M; Tilki D; De Santis M; Fanti S; Fossati N; Gillessen S; Grummet JP; Henry AM; Lardas M; Liew M; Mason M; Moris L; Schoots IG; van der Kwast T; van der Poel H; Wiegel T; Willemse PM; Rouvière O; Lam TB; Mottet N
Eur Urol Focus; 2020 Mar; 6(2):231-234. PubMed ID: 31248850
[TBL] [Abstract][Full Text] [Related]
26. Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer.
Zumsteg ZS; Zelefsky MJ; Woo KM; Spratt DE; Kollmeier MA; McBride S; Pei X; Sandler HM; Zhang Z
BJU Int; 2017 Nov; 120(5B):E87-E95. PubMed ID: 28464446
[TBL] [Abstract][Full Text] [Related]
27. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.
Adelstein D; Gillison ML; Pfister DG; Spencer S; Adkins D; Brizel DM; Burtness B; Busse PM; Caudell JJ; Cmelak AJ; Colevas AD; Eisele DW; Fenton M; Foote RL; Gilbert J; Haddad RI; Hicks WL; Hitchcock YJ; Jimeno A; Leizman D; Lydiatt WM; Maghami E; Mell LK; Mittal BB; Pinto HA; Ridge JA; Rocco J; Rodriguez CP; Shah JP; Weber RS; Witek M; Worden F; Yom SS; Zhen W; Burns JL; Darlow SD
J Natl Compr Canc Netw; 2017 Jun; 15(6):761-770. PubMed ID: 28596256
[TBL] [Abstract][Full Text] [Related]
28. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
[TBL] [Abstract][Full Text] [Related]
29. Palliative care, Version 1.2014. Featured updates to the NCCN Guidelines.
Levy MH; Smith T; Alvarez-Perez A; Back A; Baker JN; Block S; Codada SN; Dalal S; Dans M; Kutner JS; Kvale E; Misra S; Mitchell W; Sauer TM; Spiegel D; Sutton L; Taylor RM; Temel J; Tickoo R; Urba SG; Van Zyl C; Weinstein SM; Bergman MA; Scavone JL;
J Natl Compr Canc Netw; 2014 Oct; 12(10):1379-88. PubMed ID: 25313178
[TBL] [Abstract][Full Text] [Related]
30. Central Nervous System Cancers, Version 1.2015.
Nabors LB; Portnow J; Ammirati M; Baehring J; Brem H; Brown P; Butowski N; Chamberlain MC; Fenstermaker RA; Friedman A; Gilbert MR; Hattangadi-Gluth J; Holdhoff M; Junck L; Kaley T; Lawson R; Loeffler JS; Lovely MP; Moots PL; Mrugala MM; Newton HB; Parney I; Raizer JJ; Recht L; Shonka N; Shrieve DC; Sills AK; Swinnen LJ; Tran D; Tran N; Vrionis FD; Weiss S; Wen PY; McMillian N; Engh AM
J Natl Compr Canc Netw; 2015 Oct; 13(10):1191-202. PubMed ID: 26483059
[TBL] [Abstract][Full Text] [Related]
31. NCCN Guidelines Insights: Survivorship, Version 1.2016.
Denlinger CS; Ligibel JA; Are M; Baker KS; Broderick G; Demark-Wahnefried W; Friedman DL; Goldman M; Jones LW; King A; Ku GH; Kvale E; Langbaum TS; McCabe MS; Melisko M; Montoya JG; Mooney K; Morgan MA; Moslehi JJ; O'Connor T; Overholser L; Paskett ED; Peppercorn J; Rodriguez MA; Ruddy KJ; Sanft T; Silverman P; Smith S; Syrjala KL; Urba SG; Wakabayashi MT; Zee P; McMillian NR; Freedman-Cass DA
J Natl Compr Canc Netw; 2016 Jun; 14(6):715-24. PubMed ID: 27283164
[TBL] [Abstract][Full Text] [Related]
32. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Daly MB; Pilarski R; Berry M; Buys SS; Farmer M; Friedman S; Garber JE; Kauff ND; Khan S; Klein C; Kohlmann W; Kurian A; Litton JK; Madlensky L; Merajver SD; Offit K; Pal T; Reiser G; Shannon KM; Swisher E; Vinayak S; Voian NC; Weitzel JN; Wick MJ; Wiesner GL; Dwyer M; Darlow S
J Natl Compr Canc Netw; 2017 Jan; 15(1):9-20. PubMed ID: 28040716
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer. NCCN clinical practice guidelines in oncology.
National Comprehensive Cancer Network
J Natl Compr Canc Netw; 2004 May; 2(3):224-48. PubMed ID: 19795607
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.
Dess RT; Suresh K; Zelefsky MJ; Freedland SJ; Mahal BA; Cooperberg MR; Davis BJ; Horwitz EM; Terris MK; Amling CL; Aronson WJ; Kane CJ; Jackson WC; Hearn JWD; Deville C; DeWeese TL; Greco S; McNutt TR; Song DY; Sun Y; Mehra R; Kaffenberger SD; Morgan TM; Nguyen PL; Feng FY; Sharma V; Tran PT; Stish BJ; Pisansky TM; Zaorsky NG; Moraes FY; Berlin A; Finelli A; Fossati N; Gandaglia G; Briganti A; Carroll PR; Karnes RJ; Kattan MW; Schipper MJ; Spratt DE
JAMA Oncol; 2020 Dec; 6(12):1912-1920. PubMed ID: 33090219
[TBL] [Abstract][Full Text] [Related]
35. Update of the NCCN guidelines for treatment of prostate cancer.
Millikan R; Logothetis C
Oncology (Williston Park); 1997 Nov; 11(11A):180-93. PubMed ID: 9430189
[No Abstract] [Full Text] [Related]
36. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Mottet N; van den Bergh RCN; Briers E; Van den Broeck T; Cumberbatch MG; De Santis M; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Grummet J; Henry AM; van der Kwast TH; Lam TB; Lardas M; Liew M; Mason MD; Moris L; Oprea-Lager DE; van der Poel HG; Rouvière O; Schoots IG; Tilki D; Wiegel T; Willemse PM; Cornford P
Eur Urol; 2021 Feb; 79(2):243-262. PubMed ID: 33172724
[TBL] [Abstract][Full Text] [Related]
37. Screening, risk assessment, and the approach to therapy in patients with prostate cancer.
Freedland SJ
Cancer; 2011 Mar; 117(6):1123-35. PubMed ID: 20960523
[TBL] [Abstract][Full Text] [Related]
38. Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines.
Koh WJ; Greer BE; Abu-Rustum NR; Apte SM; Campos SM; Cho KR; Chu C; Cohn D; Crispens MA; Dizon DS; Dorigo O; Eifel PJ; Fisher CM; Frederick P; Gaffney DK; George S; Han E; Higgins S; Huh WK; Lurain JR; Mariani A; Mutch D; Fader AN; Remmenga SW; Reynolds RK; Tillmanns T; Valea FA; Yashar CM; McMillian NR; Scavone JL;
J Natl Compr Canc Netw; 2015 Nov; 13(11):1321-31. PubMed ID: 26553763
[TBL] [Abstract][Full Text] [Related]
39. The Swedish national guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic disease.
Bratt O; Carlsson S; Fransson P; Thellenberg Karlsson C; Stranne J; Kindblom J;
Scand J Urol; 2022 Aug; 56(4):265-273. PubMed ID: 35811480
[TBL] [Abstract][Full Text] [Related]
40. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
